Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PTC Therapeutics Inc.

www.ptcbio.com

Latest From Auxeris Therapeutics Inc.

Auxeris Therapeutics Inc.

Auxeris Therapeutics is using the cytokine RANK and its ligand as a drug target to identify anabolic bone-growth compounds.
BioPharmaceutical

Drugs that Induce Bone Growth

Inspired by the commercializing of Lilly's osteoporosis drug, Forteo, start-ups are developing new classes of anabolic bone-forming agents around known and novel drug targets.
BioPharmaceutical

Start-Up Previews (7/03)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile groups feature companies developing Drugs that Promote Bone Growth, Breast Biopsy Technologies and Cardiovascular Drugs. Plus these selected Start-Ups across Health Care: BioSeek Inc., CombinatoRx Inc. and Cyberkinetics Inc.

Selected Start-Ups (11/2002)

In Vivo briefly summarizes the technologies of these recently founded companies: Anacor Pharmaceuticals Inc., Auxeris Therapeutics Inc., Chimerix Inc., Ercole BioTech Inc., iThemba Pharmaceuticals (Pty) Ltd. and Trinity Biosystems Inc.
See All

Company Information

  • Industry
  • Biotechnology
    • Antisense, Oligonucleotides
    • Drug Discovery Tools
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • PTC Therapeutics Inc.
  • Senior Management
  • Stuart W Peltz, PhD, CEO
    Tuyen Ong, MD, CMO
    Mark A Rothera, Chief Commercial Officer
    Neil Almstead, PhD, EVP, Research, Pharma Operations & Tech.
  • Contact Info
  • PTC Therapeutics Inc.
    Phone: (908) 222-7000
    100 Corporate Ct.
    South Plainfield, NJ 07080-2449
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register